Company / R&D per Share
Lantheus Holdings R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$2.59
FY2025
5-year range
$0.67 / $5.76
FY2021-FY2025
Trend
+7.7%
vs FY2024
Sector context
#34 of 108
Health Care
What the data says
At $2.59, Lantheus Holdings's r&d per share ranks #34 of 108 in the Health Care sector. R&D per Share has fluctuated over the past 10 years, ranging from $0.32 in FY2018 to $5.76 in FY2022.
Based on SEC 10-K filings.
2.59 in FY2025 with a 5-year CAGR of +25.4%.
Improved from $1.13 to $2.59 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -23.4%
- 5-Year CAGR
- +25.4%
- 10-Year CAGR
- -
Sector benchmark
#34 of 108 in Health CareTop 31% of 108This company $2.59 Sector average $2.07
▼
+24.9% above sector average
Key checks
Key Insights
- In FY2025, r&d per share increased 7.7% year-over-year.
- Ranks #34 out of 108 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2022.
- Lowest r&d per share in the period was in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.59 | +7.7% |
| FY2024 | $2.41 | +113.2% |
| FY2023 | $1.13 | -80.4% |
| FY2022 | $5.76 | +756.3% |
| FY2021 | $0.67 | -19.5% |
| FY2020 | $0.84 | +60.5% |
| FY2019 | $0.52 | +61.1% |
| FY2018 | $0.32 | -17.3% |
| FY2017 | $0.39 | -13.3% |
| FY2016 | $0.45 | -73.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026